Login to Your Account



But They Part Ways at Trading Performance

Onconova, Conatus Price IPOs: $78M, $66M, Both with Upside

By Randy Osborne
Staff Writer

Friday, July 26, 2013

Onconova Therapeutics Inc. priced its shares higher than expected in an initial public offering (IPO), and Conatus Pharmaceuticals Inc., also pricing, rolled out 1 million more shares than originally targeted, to settle in the midrange of the targeted cost per share.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription